Literature DB >> 19774352

Lidocaine 2% jelly versus lidocaine 2%-sodium hyaluronate 0.3% drops in phacoemulsification surgery.

Irini P Chatziralli, Leonidas Papazisis, Theodoros N Sergentanis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19774352     DOI: 10.1007/s00417-009-1194-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  5 in total

1.  Corneal-wetting property of lignocaine 2% jelly.

Authors:  Thandalam S Kalyanasundaram; Mahmood Hasan
Journal:  J Cataract Refract Surg       Date:  2002-08       Impact factor: 3.351

2.  Tetracaine hydrochloride 0.5% versus lidocaine 2% jelly as a topical anesthetic agent in cataract surgery: comparative clinical trial.

Authors:  Howard Amiel; Paul S Koch
Journal:  J Cataract Refract Surg       Date:  2007-01       Impact factor: 3.351

3.  Mydriasis with different preparations of topically administered lidocaine hydrochloride.

Authors:  Martin Claesson; Magdalena Johansson; Anders Behndig
Journal:  J Cataract Refract Surg       Date:  2009-02       Impact factor: 3.351

4.  Comparative clinical trial of topical anesthetic agents in cataract surgery: lidocaine 2% gel, bupivacaine 0.5% drops, and benoxinate 0.4% drops.

Authors:  Mahmoud M Soliman; Tamer A Macky; M Khaled Samir
Journal:  J Cataract Refract Surg       Date:  2004-08       Impact factor: 3.351

5.  Effect of application duration of 2% lidocaine jelly on aqueous lidocaine concentration for topical anesthesia in cataract surgery.

Authors:  Alvin K H Kwok; Timothy Y Y Lai; Vincent Y W Lee; Yat-Shan Yeung; Kai-On Chu; Calvin C P Pang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-02-17       Impact factor: 3.117

  5 in total
  1 in total

1.  Viscoat versus Visthesia during phacoemulsification cataract surgery: corneal and foveal changes.

Authors:  Marilita M Moschos; Irini P Chatziralli; Theodoros N Sergentanis
Journal:  BMC Ophthalmol       Date:  2011-04-29       Impact factor: 2.209

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.